The common denominator of this group of disorders is bleeding due to antibody-mediated platelet destruction. The variations in clinical manifestations—ranging from mild to fatal—reflect the diverse origins of the troublesome antibodies: transplacental, exogenous, and autogenous. Treatment—if necessary—may involve steroids, exchange transfusion, apheresis, or splenectomy.